7.3 Split-Night Protocols & AASM Titration Quality Grading

7.3 Split-Night Protocols & AASM Titration Quality Grading

Quick Answer: A split-night polysomnogram combines a diagnostic baseline PSG and a PAP titration into a single night. To initiate split-night titration, AASM criteria require: 1) a minimum diagnostic recording of $\ge 2.0\text{ hours}$ ($120\text{ min}$), 2) an $\text{AHI} \ge 40.0\text{ events/hour}$ (or $20\text{--}40\text{ events/hr}$ with clinical urgency/severe desaturation), 3) a minimum remaining titration duration of $\ge 3.0\text{ hours}$ ($180\text{ min}$), and 4) a signed physician split-night order. Titration quality is graded as: Optimal ($\text{RDI} < 5/\text{hr}$ for $\ge 15\text{ min}$ including supine REM, $SpO_2 > 90%$), Good ($\text{RDI} \le 10/\text{hr}$ or $\ge 50%$ reduction, including supine REM, $SpO_2 > 90%$), Adequate ($\text{RDI} \le 10/\text{hr}$ or $\ge 50%$ reduction, but NO supine REM), and Unacceptable (fails adequate criteria or high leak $>24\text{ L/min}$), requiring a repeat study.

Split-night polysomnography offers an efficient clinical pathway to diagnose and initiate treatment for severe obstructive sleep apnea within a single nocturnal laboratory session. Technologists must rigorously evaluate real-time diagnostic indices and apply AASM titration grading definitions to ensure safe and effective clinical outcomes.

---

1. Split-Night Protocol Prerequisites & AASM Eligibility Criteria

A split-night protocol divides a standard nocturnal recording into two distinct sequential phases:

1. Diagnostic Baseline Phase: Standard polysomnographic monitoring without positive airway pressure to document baseline sleep-disordered breathing severity and sleep architecture.
2. Therapeutic Titration Phase: Application of PAP therapy (CPAP or BiPAP) to establish the optimal therapeutic pressure.

+---------------------------------------------------------------------------------------------------+
|                                SPLIT-NIGHT TIME ALLOCATION TIMELINE                               |
|                                                                                                   |
|   |<--------------------------- Total Recording Time (TRT >= 6.0 to 7.0 Hours) ------------------->|
|                                                                                                   |
|   |<- Diagnostic Baseline (Min >= 2.0 Hours) ->|<--- Therapeutic PAP Titration (Min >= 3.0 Hours) ->|
|   | Lights Out                                 | Mask Application                             Lights On
|   |                                            | & PAP Initiation                                 |
|   +--------------------------------------------+--------------------------------------------------+
|   | • Measure Diagnostic AHI                   | • Start CPAP @ 4 cm H2O (or BiPAP @ 8/4)        |
|   | • Criterion: AHI >= 40.0/hr                | • Increase pressure for apneas/hypopneas/RERAs   |
|   | • Document SpO2 nadir & cardiac rhythm    | • Capture Supine Stage REM Sleep                 |
+---------------------------------------------------------------------------------------------------+

Mandatory AASM Split-Night Criteria Checklist

• Criterion 1 — Baseline Duration: A minimum of $2.0\text{ hours}$ ($120\text{ minutes}$) of diagnostic recording must be completed. Technologists should ensure that this interval contains confirmed physiological sleep rather than prolonged wakefulness.
• Criterion 2 — Diagnostic Severity Cutoff: An $\text{AHI} \ge 40.0\text{ events/hour}$ must be documented during the baseline recording. AASM clinical practice guidelines allow split-night initiation at an AHI between $20.0\text{ and }39.9\text{ events/hour}$ if accompanied by prolonged severe oxyhemoglobin desaturations ($SpO_2 < 80%$ for sustained periods), life-threatening cardiac dysrhythmias, or when explicitly defined by laboratory clinical standing orders.
• Criterion 3 — Remaining Titration Window: A minimum of $3.0\text{ hours}$ ($180\text{ minutes}$) of available recording time must remain on PAP to perform a comprehensive titration across sleep stages and body positions.
• Criterion 4 — Physician Authorization: A valid physician prescription or accredited facility clinical protocol authorizing split-night execution must be present in the patient's medical record.

Exam Trap Alert (Split-Night Timing): If a patient achieves an $\text{AHI} \ge 40\text{ events/hour}$ in the first 45 minutes of sleep, the technologist CANNOT immediately initiate PAP. The full $2.0\text{ hours}$ of baseline recording must be completed before transitioning to the titration phase.

---

2. In-Lab Split-Night Execution & Workflow Protocol

To ensure seamless execution, the sleep technologist follows a structured protocol:

1. Pre-Study Interface Fitting: Prior to Lights Out, fit the patient with an appropriate mask interface, connect the patient to the PAP unit, and demonstrate positive airway pressure for 5–10 minutes while awake. This desensitization step eliminates anxiety and fitting delays during the midnight transition.
2. Real-Time Baseline Scoring: Score sleep stages, apneas, hypopneas, and desaturations online in real time. Calculate running baseline AHI and TST continuously.
3. Transition Initiation: Once $2.0\text{ hours}$ have elapsed and the $\text{AHI} \ge 40\text{ events/hr}$ threshold is satisfied, enter the patient's bedroom during a natural arousal or awaken the patient gently with minimal room lighting.
4. PAP Application & Titration: Secure the interface, turn on the PAP device at the starting pressure ($4\text{ cm H}_2\text{O}$ CPAP or $8/4\text{ cm H}_2\text{O}$ BiPAP), and execute the AASM titration algorithm.
5. Positional and Sleep-Stage Challenge: Actively encourage the patient to assume the supine sleeping position during the latter half of the titration phase to ensure that the final pressure is sufficient to overcome maximal gravitational upper airway collapse during Stage REM sleep.

---

3. AASM Titration Quality Grading System

The American Academy of Sleep Medicine established a standardized quality grading framework to evaluate the clinical efficacy of an in-lab PAP titration study. Quality grades are determined by respiratory event control, oxygenation, and sleep architecture representation.

+-----------------------------------------------------------------------------------------+
|                         AASM TITRATION QUALITY GRADING SPECTRUM                         |
|                                                                                         |
|   [ OPTIMAL TITRATION ]                                                                 |
|   * RDI < 5.0 events/hour for >= 15 continuous minutes at selected pressure.            |
|   * MUST include SUPINE Stage REM sleep.                                                |
|   * SpO2 > 90.0% at selected pressure.                                                  |
|                                                                                         |
|   [ GOOD TITRATION ]                                                                    |
|   * RDI <= 10.0 events/hour (or >=50% reduction if baseline RDI < 15).                  |
|   * MUST include SUPINE Stage REM sleep.                                                |
|   * SpO2 > 90.0% at selected pressure.                                                  |
|                                                                                         |
|   [ ADEQUATE TITRATION ]                                                                |
|   * RDI <= 10.0 events/hour (or >=50% reduction if baseline RDI < 15).                  |
|   * Does NOT include Supine Stage REM sleep (e.g. Lateral only, or no REM).             |
|   * SpO2 > 90.0% at selected pressure.                                                  |
|                                                                                         |
|   [ UNACCEPTABLE TITRATION ]                                                            |
|   * Fails to meet Adequate criteria (persistent RDI > 10, or SpO2 < 90%).               |
|   * Unresolved severe mask leak (>24 L/min) or total PAP sleep time < 3 hours.          |
|   * Action: Requires a full-night repeat titration study.                               |
+-----------------------------------------------------------------------------------------+

Detailed Quality Grade Specifications

1. Optimal Titration

• Respiratory Target: Reduces the Respiratory Disturbance Index (RDI) to $< 5.0\text{ events/hour}$ for a minimum of $15\text{ continuous minutes}$.
• Sleep Architecture Requirement: Must capture Stage REM sleep in the supine position at the selected pressure.
• Oximetry Target: Mean and minimum $SpO_2$ remain $> 90.0%$ at the selected pressure.
• Arousal & Snoring Control: Eliminates all spontaneous and respiratory-related EEG arousals and abolishes snoring.

2. Good Titration

• Respiratory Target: Reduces RDI to $\le 10.0\text{ events/hour}$ (or achieves a $\ge 50%$ reduction from baseline if the baseline diagnostic RDI was $< 15.0\text{ events/hr}$).
• Sleep Architecture Requirement: Must capture Stage REM sleep in the supine position at the selected pressure.
• Oximetry Target: $SpO_2 > 90.0%$ at the selected pressure.

3. Adequate Titration

• Respiratory Target: Reduces RDI to $\le 10.0\text{ events/hour}$ (or achieves a $\ge 50%$ reduction from baseline).
• Sleep Architecture Limitation: Fails to capture Stage REM sleep in the supine position (e.g., patient slept only in the lateral position, or spent no time in REM sleep at the final pressure setting).
• Oximetry Target: $SpO_2 > 90.0%$ at the selected pressure.
• Clinical Implication: Acceptable for initial home prescription, but patient must be monitored closely for breakthrough obstructive events during supine REM sleep at home.

4. Unacceptable Titration

• Criteria: Fails to meet criteria for Adequate titration; persistent RDI $> 10.0\text{ events/hr}$; persistent hypoxemia ($SpO_2 < 90%$); excessive uncorrectable unintentional mask leak ($>24\text{ L/min}$); or total sleep time on PAP $< 3.0\text{ hours}$.
• Clinical Action: The patient must be scheduled for a dedicated full-night repeat CPAP/BiPAP titration study.

---

4. Split-Night Protocols vs. Quality Grading Matrix